NCT00149643View on ClinicalTrials.gov

Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2009

Study Completion Date

December 31, 2012

Conditions
Depressive Disorder, MajorCannabis Abuse
Interventions
DRUG

Fluoxetine

Gelatin capsules Fluoxetine 10 mg, 1 capsule every a.m. Medication will be increased by one capsule, to a daily dose of fluoxetine 20 mg, 2 capsules barring side effects.

OTHER

Placebo

Gelatin capsules Placebo capsules, identical to Fluoxetine capsules, 1 capsule every a.m. Medication will be increased by one capsule, to a daily dose of placebo, 2 capsules barring side effects.

Trial Locations (1)

15213

Department of Psychiatry, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pittsburgh

OTHER

NCT00149643 - Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence | Biotech Hunter | Biotech Hunter